{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:32:53Z","timestamp":1768077173738,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"DOI":"10.7759\/cureus.41422","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T23:24:55Z","timestamp":1688599495000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Safety and Efficacy of Naloxegol in Critically Ill Opioid-Induced Constipation Patients"],"prefix":"10.7759","author":[{"given":"M. Zeeshan","family":"Rizwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Nei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2009.03.007","article-title":"Constipation in intensive care unit: incidence and risk factors","volume":"24","author":"Nassar AP Jr","year":"2009","unstructured":"Nassar AP Jr, da Silva FM, de Cleva R. Constipation in intensive care unit: incidence and risk factors. J Crit Care. 2009, 24:630.e9-12. 10.1016\/j.jcrc.2009.03.007","journal-title":"J Crit Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5935\/0103-507X.20130014","article-title":"Constipation in critically ill patients: much more than we imagine","volume":"25","author":"de Azevedo RP","year":"2013","unstructured":"de Azevedo RP, Machado FR. Constipation in critically ill patients: much more than we imagine. Rev Bras Ter Intensiva. 2013, 25:73-4. 10.5935\/0103-507X.20130014","journal-title":"Rev Bras Ter Intensiva"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin JW","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, et al.. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018, 46:e825-73. 10.1097\/CCM.0000000000003299","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.15852","article-title":"Medical management of opioid-induced constipation","volume":"322","author":"Rao VL","year":"2019","unstructured":"Rao VL, Micic D, Davis AM. Medical management of opioid-induced constipation. JAMA. 2019, 322:2241-2. 10.1001\/jama.2019.15852","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg275","article-title":"Constipation and its implications in the critically ill patient","volume":"91","author":"Mostafa SM","year":"2003","unstructured":"Mostafa SM, Bhandari S, Ritchie G, Gratton N, Wenstone R. Constipation and its implications in the critically ill patient. Br J Anaesth. 2003, 91:815-19. 10.1093\/bja\/aeg275","journal-title":"Br J Anaesth"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/cc5685","article-title":"The impact of admission diagnosis on gastric emptying in critically ill patients","volume":"11","author":"Nguyen NQ","year":"2007","unstructured":"Nguyen NQ, Ng MP, Chapman M, Fraser RJ, Holloway RH. The impact of admission diagnosis on gastric emptying in critically ill patients. Crit Care. 2007, 11:R16. 10.1186\/cc5685","journal-title":"Crit Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709548","article-title":"Impaired gastric emptying in mechanically ventilated, critically ill patients","volume":"22","author":"Heyland DK","year":"1996","unstructured":"Heyland DK, Tougas G, King D, Cook DJ. Impaired gastric emptying in mechanically ventilated, critically ill patients. Intensive Care Med. 1996, 22:1339-44. 10.1007\/BF01709548","journal-title":"Intensive Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S99412","article-title":"Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem","volume":"11","author":"Yoon SC","year":"2017","unstructured":"Yoon SC, Bruner HC. Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem. Patient Prefer Adherence. 2017, 11:1265-71. 10.2147\/PPA.S99412","journal-title":"Patient Prefer Adherence"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/141737","article-title":"Opioid-induced constipation: pathophysiology, clinical consequences, and management","volume":"2014","author":"Kumar L","year":"2014","unstructured":"Kumar L, Barker C, Emmanuel A. Opioid-induced constipation: pathophysiology, clinical consequences, and management. Gastroenterol Res Pract. 2014, 2014:141737. 10.1155\/2014\/141737","journal-title":"Gastroenterol Res Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-013-0334-4","article-title":"Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies","volume":"15","author":"Sharma A","year":"2013","unstructured":"Sharma A, Jamal MM. Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies. Curr Gastroenterol Rep. 2013, 15:334. 10.1007\/s11894-013-0334-4","journal-title":"Curr Gastroenterol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1711","article-title":"Novel oral therapies for opioid-induced bowel dysfunction in patients with chronic noncancer pain","volume":"36","author":"Holder RM","year":"2016","unstructured":"Holder RM, Rhee D. Novel oral therapies for opioid-induced bowel dysfunction in patients with chronic noncancer pain. Pharmacotherapy. 2016, 36:287-99. 10.1002\/phar.1711","journal-title":"Pharmacotherapy"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12899","article-title":"Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation","volume":"40","author":"Webster L","year":"2014","unstructured":"Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther. 2014, 40:771-9. 10.1111\/apt.12899","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2015.51.8.2364896","article-title":"Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation","volume":"51","author":"Corsetti M","year":"2015","unstructured":"Corsetti M, Tack J. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation. Drugs Today (Barc). 2015, 51:479-89. 10.1358\/dot.2015.51.8.2364896","journal-title":"Drugs Today (Barc)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310246","article-title":"Naloxegol for opioid-induced constipation in patients with noncancer pain","volume":"370","author":"Chey WD","year":"2014","unstructured":"Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014, 370:2387-96. 10.1056\/NEJMoa1310246","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1074248418760239","article-title":"Cardiovascular safety of the selective \u03bc-opioid receptor antagonist naloxegol: a novel therapy for opioid-induced constipation","volume":"23","author":"White WB","year":"2018","unstructured":"White WB, Kowey P, Diva U, Sostek M, Tummala R. Cardiovascular safety of the selective \u03bc-opioid receptor antagonist naloxegol: a novel therapy for opioid-induced constipation. J Cardiovasc Pharmacol Ther. 2018, 23:309-17. 10.1177\/1074248418760239","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.09.019","article-title":"Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT\/QTc study in healthy volunteers","volume":"35","author":"Gottfridsson C","year":"2013","unstructured":"Gottfridsson C, Carlson G, Lappalainen J, Sostek M. Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT\/QTc study in healthy volunteers. Clin Ther. 2013, 35:1876-83. 10.1016\/j.clinthera.2013.09.019","journal-title":"Clin Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12234","article-title":"Does withdrawal seizure occur in opioid dependence syndrome? A case series","volume":"69","author":"Khanra S","year":"2015","unstructured":"Khanra S, Mahintamani T, Khess CR. Does withdrawal seizure occur in opioid dependence syndrome? A case series. Psychiatry Clin Neurosci. 2015, 69:238-9. 10.1111\/pcn.12234","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.04.024","article-title":"A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation","volume":"154","author":"Webster L","year":"2013","unstructured":"Webster L, Dhar S, Eldon M, Masuoka L, Lappalainen J, Sostek M. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain. 2013, 154:1542-50. 10.1016\/j.pain.2013.04.024","journal-title":"Pain"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245368","article-title":"Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital","volume":"16","author":"Murali M","year":"2021","unstructured":"Murali M, Suppes SL, Feldman K, Goldman JL. Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital. PLoS One. 2021, 16:e0245368. 10.1371\/journal.pone.0245368","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute Guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett SD","year":"2019","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S. American Gastroenterological Association Institute Guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019, 156:218-26. 10.1053\/j.gastro.2018.07.016","journal-title":"Gastroenterology"},{"key":"ref21","unstructured":"Intestinal obstruction. (2021). Accessed. March 29, 2022: https:\/\/www.mayoclinic.org\/diseases-conditions\/intestinal-obstruction\/symptoms-causes\/syc-20351460."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149309-evaluating-the-safety-and-efficacy-of-naloxegol-in-critically-ill-opioid-induced-constipation-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:50Z","timestamp":1707508970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149309-evaluating-the-safety-and-efficacy-of-naloxegol-in-critically-ill-opioid-induced-constipation-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.41422","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,5]]}}}